Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

被引:91
作者
Perlis, Roy H. [1 ,2 ,3 ]
Ostacher, Michael J. [1 ,2 ,3 ]
Miklowitz, David J. [4 ]
Hay, Aleena [1 ,2 ,3 ]
Nierenberg, Andrew A. [1 ,2 ,3 ]
Thase, Michael E. [5 ]
Sachs, Gary S. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Bipolar Clin & Res Program, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA
[5] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
TREATMENT ENHANCEMENT PROGRAM; MEDICATION ADHERENCE; INCREASE ADHERENCE; LITHIUM; RISK; INDIVIDUALS; VALIDATION; PREDICTORS; ALGORITHMS; OUTCOMES;
D O I
10.4088/JCP.09m05514yel
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Poor medication adherence is common among bipolar patients. Method: We examined prospective data from 2 cohorts of individuals from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (1999-2005) with bipolar disorder. Clinical and sociodemographic features associated with missing at least 25% of doses of at least 1 medication were assessed using logistic regression, and a risk stratification model was developed and validated. Results: Of 3,640 subjects with 48,287 follow-up visits, 871 (24%) reported nonadherence on 20% or more study visits. Clinical features significantly associated (P<.05) with poor adherence included rapid cycling, suicide attempts, earlier onset of illness, and current anxiety or alcohol use disorder. Nonadherence during the first 3 months of follow-up was associated with less improvement in functioning at 12-month follow-up (P<.03). A risk stratification model using clinical predictors accurately classified 80.6% of visits in an independent validation cohort. Conclusion: Risk for poor medication adherence can be estimated and may be useful in targeting interventions. J Clin Psychiatry 2010;71(3):296-303 (C) Copyright 2010 Physicians Postgraduate Press, Inc.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 50 条
  • [21] Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Magalhaes, Pedro Vieira
    Dodd, Seetal
    Nierenberg, Andrew A.
    Berk, Michael
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (11) : 1058 - 1067
  • [22] Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Dennehy, Ellen B.
    Marangell, Lauren B.
    Allen, Michael H.
    Chessick, Cheryl
    Wisniewski, Stephen R.
    Thase, Michael E.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2011, 133 (03) : 423 - 427
  • [23] Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data
    Mousavi, Zahra
    Johnson, Sheri
    Li, Descartes
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 236 : 136 - 139
  • [24] Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment
    Stange, Jonathan P.
    Sylvia, Louisa G.
    da Silva Magalhaes, Pedro Vieira
    Miklowitz, David J.
    Otto, Michael W.
    Frank, Ellen
    Yim, Christine
    Berk, Michael
    Dougherty, Darin D.
    Nierenberg, Andrew A.
    Deckersbach, Thilo
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (04) : 352 - 358
  • [25] Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Bareis, Natalie
    Lu, Juan
    Kirkwood, Cynthia K.
    Kornstein, Susan G.
    Wu, Elwin
    Mezuk, Briana
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 238 : 147 - 155
  • [26] Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study
    Machado-Vieira, Rodrigo
    Luckenbaugh, David A.
    Ballard, Elizabeth D.
    Henter, Ioline D.
    Tohen, Mauricio
    Suppes, Trisha
    Zarate, Carlos A., Jr.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (01) : 70 - 76
  • [27] Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment
    Stange, Jonathan P.
    Sylvia, Louisa G.
    da Silva Magalhaes, Pedro Vieira
    Miklowitz, David J.
    Otto, Michael W.
    Frank, Ellen
    Berk, Michael
    Nierenberg, Andrew A.
    Deckersbach, Thilo
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (03) : 249 - 255
  • [28] An evaluation of the impact of co-occurring anxiety and substance use disorder on bipolar disorder illness outcomes in STEP-BD
    Prisciandaro, James J.
    Mellick, William
    Mitaro, Emily
    Tolliver, Bryan K.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 246 : 794 - 799
  • [29] Impact of Substance Use Disorders on Recovery From Episodes of Depression in Bipolar Disorder Patients: Prospective Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Ostacher, Michael J.
    Perlis, Roy H.
    Nierenberg, Andrew A.
    Calabrese, Joseph
    Stange, Jonathan P.
    Salloum, Ihsan
    Weiss, Roger D.
    Sachs, Gary S.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (03) : 289 - 297
  • [30] Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)
    Vieta, Eduard
    Langosch, Jens M.
    Figueira, Maria Luisa
    Souery, Daniel
    Blasco-Colmenares, Elena
    Medina, Esteban
    Moreno-Manzanaro, Miriam
    Angel Gonzalez, Miguel
    Bellivier, Frank
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (08) : 1719 - 1732